New genetic discoveries highlight why certain brain cells are more vulnerable in Parkinson's

New genetic discoveries highlight why certain brain cells are more vulnerable in Parkinson's

June 8, 2026

Scientists have long wondered why a specific group of brain cells breaks down in Parkinson's while neighbouring cells stay perfectly healthy. These vulnerable cells are responsible for making dopamine, a vital chemical messenger that helps control smooth movement. A new study has provided crucial answers by looking at how specific genes work together inside these cells, revealing why some neurons are at much higher risk than others. Inside every cell, tiny powerhouses called mitochondria produce the energy needed to keep the cell alive. Because making dopamine is hard work, these powerhouses experience a lot of wear and tear, meaning they need constant maintenance. A well known gene called PRKN normally acts as a quality control manager, helping the cell clear away old, damaged powerhouses before they can cause internal harm. The new research shows that when this quality control system fails, a chain reaction triggers two other important genes, known as CHCHD2 and GPNMB. Under normal circumstances, the first gene acts as a structural shield to keep the powerhouses stable. The study found that when the main quality control system breaks down, this protective shield drops significantly, leaving the cell defenceless. To try and cope with this sudden vulnerability, the cell activates the second gene, which acts as an emergency stress responder. This responder tries its best to clean up the toxic waste building up inside the cell. However, because dopamine producing cells already face immense daily stress, losing their structural shield puts too much pressure on the emergency cleanup crew, and the cells eventually stop working. For people living with Parkinson's, this discovery is incredibly important because it changes how scientists look for new treatments. Instead of trying to protect every single cell in the brain with a general medicine, scientists can now focus on developing targeted therapies. Future treatments could be designed specifically to boost the protective shield gene or to assist the emergency cleanup gene, helping to keep these vital dopamine producing cells alive and healthy for much longer.

Comments (0)

Loading comments...